The future promises a digitally connected healthcare system that empowers both patients and carers alike. So, what’s the next step for pharma companies and device developers with ambitions in the space?
![Digital biomarkers for patient-empowering connected health](https://www.cambridgeconsultants.com/wp-content/uploads/2023/10/Featured_Blog_Biomarkers.jpg?w=550&h=425&crop=1)
Author profile
Joe brings products to market for drug delivery, diagnostics and minimally invasive surgery, having led the R&D of high risk (class 3) devices, including the regulatory approach and development of mechanical, electronic and software solutions, utilising the latest developments in Statistical Machine Learning, data science and Artificial Intelligence.